

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 7.73107228 |
| 2 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 7.73107228 |
| 3 | peripheral nervous system neuron development (GO:0048935) | 7.57144101 |
| 4 | sequestering of actin monomers (GO:0042989) | 7.48815628 |
| 5 | detection of temperature stimulus (GO:0016048) | 6.74951736 |
| 6 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 6.40991880 |
| 7 | response to water (GO:0009415) | 5.63306079 |
| 8 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.54188600 |
| 9 | low-density lipoprotein particle clearance (GO:0034383) | 5.24128562 |
| 10 | behavioral response to pain (GO:0048266) | 5.15305979 |
| 11 | aggressive behavior (GO:0002118) | 5.04527302 |
| 12 | response to pain (GO:0048265) | 4.92545258 |
| 13 | neuronal action potential (GO:0019228) | 4.89051721 |
| 14 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.77852172 |
| 15 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.77141949 |
| 16 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.55283648 |
| 17 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.47430035 |
| 18 | negative regulation of amino acid transport (GO:0051956) | 4.36820411 |
| 19 | positive regulation of macrophage differentiation (GO:0045651) | 4.32649600 |
| 20 | negative regulation of heart rate (GO:0010459) | 4.30923211 |
| 21 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.24805916 |
| 22 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 4.21622858 |
| 23 | adenosine metabolic process (GO:0046085) | 4.18476512 |
| 24 | neurofilament cytoskeleton organization (GO:0060052) | 4.15248360 |
| 25 | protein neddylation (GO:0045116) | 3.96685969 |
| 26 | cell migration in hindbrain (GO:0021535) | 3.94276757 |
| 27 | protein retention in ER lumen (GO:0006621) | 3.93933788 |
| 28 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.84075929 |
| 29 | fatty acid homeostasis (GO:0055089) | 3.82175500 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 3.75583598 |
| 31 | response to dietary excess (GO:0002021) | 3.69756594 |
| 32 | daunorubicin metabolic process (GO:0044597) | 3.67489798 |
| 33 | polyketide metabolic process (GO:0030638) | 3.67489798 |
| 34 | doxorubicin metabolic process (GO:0044598) | 3.67489798 |
| 35 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.67371924 |
| 36 | biotin metabolic process (GO:0006768) | 3.67011207 |
| 37 | regulation of platelet aggregation (GO:0090330) | 3.64592259 |
| 38 | regulation of sequestering of triglyceride (GO:0010889) | 3.60864993 |
| 39 | regulation of dopamine secretion (GO:0014059) | 3.59418294 |
| 40 | regulation of cholesterol storage (GO:0010885) | 3.55427012 |
| 41 | white fat cell differentiation (GO:0050872) | 3.53511932 |
| 42 | triglyceride catabolic process (GO:0019433) | 3.51092932 |
| 43 | neuronal action potential propagation (GO:0019227) | 3.50945756 |
| 44 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.49217975 |
| 45 | membrane budding (GO:0006900) | 3.49051121 |
| 46 | L-serine transport (GO:0015825) | 3.46117256 |
| 47 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.44602322 |
| 48 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.40666538 |
| 49 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.33353995 |
| 50 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 3.32122653 |
| 51 | acylglycerol catabolic process (GO:0046464) | 3.27488128 |
| 52 | neutral lipid catabolic process (GO:0046461) | 3.27488128 |
| 53 | serine transport (GO:0032329) | 3.24692175 |
| 54 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.23841040 |
| 55 | neuron fate specification (GO:0048665) | 3.23822351 |
| 56 | respiratory electron transport chain (GO:0022904) | 3.23471218 |
| 57 | negative regulation of cation channel activity (GO:2001258) | 3.23354586 |
| 58 | astrocyte differentiation (GO:0048708) | 3.21515582 |
| 59 | retinal ganglion cell axon guidance (GO:0031290) | 3.21012124 |
| 60 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.18963044 |
| 61 | enteric nervous system development (GO:0048484) | 3.14958091 |
| 62 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.14014094 |
| 63 | negative thymic T cell selection (GO:0045060) | 3.13948291 |
| 64 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.13609323 |
| 65 | electron transport chain (GO:0022900) | 3.12246745 |
| 66 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.11976370 |
| 67 | negative regulation of humoral immune response (GO:0002921) | 3.11588329 |
| 68 | potassium ion export (GO:0071435) | 3.10947081 |
| 69 | negative T cell selection (GO:0043383) | 3.10776510 |
| 70 | negative regulation of dendrite development (GO:2000171) | 3.07833071 |
| 71 | negative regulation of neurological system process (GO:0031645) | 3.06784460 |
| 72 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.06633692 |
| 73 | negative regulation of B cell mediated immunity (GO:0002713) | 3.06633692 |
| 74 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.06575123 |
| 75 | positive regulation of mitochondrial fission (GO:0090141) | 3.06503391 |
| 76 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.05868775 |
| 77 | positive regulation of granulocyte differentiation (GO:0030854) | 3.05424343 |
| 78 | membrane depolarization during action potential (GO:0086010) | 3.04902918 |
| 79 | regulation of phospholipase A2 activity (GO:0032429) | 3.02056881 |
| 80 | cellular response to ATP (GO:0071318) | 3.01761193 |
| 81 | plasma lipoprotein particle clearance (GO:0034381) | 2.98483325 |
| 82 | L-serine metabolic process (GO:0006563) | 2.98199121 |
| 83 | ribosomal small subunit biogenesis (GO:0042274) | 2.98188480 |
| 84 | GTP biosynthetic process (GO:0006183) | 2.97219934 |
| 85 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.96032586 |
| 86 | oligosaccharide catabolic process (GO:0009313) | 2.95327204 |
| 87 | regulation of mitochondrial translation (GO:0070129) | 2.94007184 |
| 88 | negative regulation of complement activation (GO:0045916) | 2.91849802 |
| 89 | urinary tract smooth muscle contraction (GO:0014848) | 2.91155542 |
| 90 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.91116994 |
| 91 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.89493862 |
| 92 | alpha-linolenic acid metabolic process (GO:0036109) | 2.88745603 |
| 93 | positive regulation of tolerance induction (GO:0002645) | 2.88223830 |
| 94 | brown fat cell differentiation (GO:0050873) | 2.87610760 |
| 95 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.84639018 |
| 96 | tachykinin receptor signaling pathway (GO:0007217) | 2.84165055 |
| 97 | glycosphingolipid catabolic process (GO:0046479) | 2.82044522 |
| 98 | positive regulation of steroid hormone secretion (GO:2000833) | 2.81951389 |
| 99 | metallo-sulfur cluster assembly (GO:0031163) | 2.81818117 |
| 100 | iron-sulfur cluster assembly (GO:0016226) | 2.81818117 |
| 101 | regulation of histone phosphorylation (GO:0033127) | 2.81661890 |
| 102 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.81635789 |
| 103 | L-phenylalanine metabolic process (GO:0006558) | 2.81635789 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.79802842 |
| 105 | ATP synthesis coupled proton transport (GO:0015986) | 2.76134691 |
| 106 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.76134691 |
| 107 | cellular response to prostaglandin stimulus (GO:0071379) | 2.74598161 |
| 108 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.72512999 |
| 109 | positive regulation of amino acid transport (GO:0051957) | 2.70800187 |
| 110 | protein maturation by protein folding (GO:0022417) | 2.70219206 |
| 111 | GDP-mannose metabolic process (GO:0019673) | 2.70168424 |
| 112 | positive regulation of cholesterol efflux (GO:0010875) | 2.69359275 |
| 113 | G-protein coupled receptor internalization (GO:0002031) | 2.68766888 |
| 114 | cellular response to interleukin-15 (GO:0071350) | 2.67736774 |
| 115 | DNA deamination (GO:0045006) | 2.67585397 |
| 116 | UTP biosynthetic process (GO:0006228) | 2.67179355 |
| 117 | negative regulation of actin filament polymerization (GO:0030837) | 2.66276314 |
| 118 | hyperosmotic salinity response (GO:0042538) | 2.66258334 |
| 119 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.65861625 |
| 120 | cellular response to nicotine (GO:0071316) | 2.64988795 |
| 121 | triglyceride biosynthetic process (GO:0019432) | 2.64889148 |
| 122 | glycerolipid catabolic process (GO:0046503) | 2.64760558 |
| 123 | imidazole-containing compound metabolic process (GO:0052803) | 2.64254564 |
| 124 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.63465225 |
| 125 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.63465225 |
| 126 | regulation of tolerance induction (GO:0002643) | 2.63256498 |
| 127 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.62870252 |
| 128 | positive regulation of immunoglobulin production (GO:0002639) | 2.62779996 |
| 129 | acrosome reaction (GO:0007340) | 2.61795923 |
| 130 | response to interleukin-15 (GO:0070672) | 2.60470594 |
| 131 | signal peptide processing (GO:0006465) | 2.60296767 |
| 132 | thymic T cell selection (GO:0045061) | 2.59791806 |
| 133 | negative regulation of telomerase activity (GO:0051974) | 2.59255687 |
| 134 | protein complex biogenesis (GO:0070271) | 2.58836864 |
| 135 | microtubule polymerization or depolymerization (GO:0031109) | 2.57587022 |
| 136 | protein polyglutamylation (GO:0018095) | 2.57542080 |
| 137 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.56368251 |
| 138 | regulation of superoxide anion generation (GO:0032928) | 2.55570921 |
| 139 | action potential (GO:0001508) | 2.54935967 |
| 140 | sensory perception of pain (GO:0019233) | 2.54544888 |
| 141 | diacylglycerol metabolic process (GO:0046339) | 2.54428668 |
| 142 | glycolipid catabolic process (GO:0019377) | 2.53537164 |
| 143 | NADH metabolic process (GO:0006734) | 2.52234226 |
| 144 | neutral lipid biosynthetic process (GO:0046460) | 2.51057841 |
| 145 | acylglycerol biosynthetic process (GO:0046463) | 2.51057841 |
| 146 | UTP metabolic process (GO:0046051) | 2.50556052 |
| 147 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.50419104 |
| 148 | glycoside metabolic process (GO:0016137) | 2.50061583 |
| 149 | negative regulation of microtubule polymerization (GO:0031115) | 2.49650942 |
| 150 | regulation of telomerase activity (GO:0051972) | 2.49633721 |
| 151 | CTP metabolic process (GO:0046036) | 2.49205690 |
| 152 | CTP biosynthetic process (GO:0006241) | 2.49205690 |
| 153 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.48533407 |
| 154 | chaperone-mediated protein transport (GO:0072321) | 2.48371640 |
| 155 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.48097100 |
| 156 | regulation of neurotransmitter uptake (GO:0051580) | 2.47797973 |
| 157 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.46933918 |
| 158 | glial cell migration (GO:0008347) | 2.46471875 |
| 159 | tricarboxylic acid metabolic process (GO:0072350) | 2.46237469 |
| 160 | response to phenylpropanoid (GO:0080184) | 2.45908551 |
| 161 | negative regulation of Ras GTPase activity (GO:0034261) | 2.45373182 |
| 162 | regulation of proton transport (GO:0010155) | 2.45229551 |
| 163 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.44328913 |
| 164 | axoneme assembly (GO:0035082) | 2.44156573 |
| 165 | negative regulation of protein polymerization (GO:0032272) | 2.43899791 |
| 166 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.43845021 |
| 167 | peristalsis (GO:0030432) | 2.43688885 |
| 168 | response to ATP (GO:0033198) | 2.43567414 |
| 169 | negative regulation of sodium ion transport (GO:0010766) | 2.43388546 |
| 170 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.43365445 |
| 171 | peroxisome fission (GO:0016559) | 2.43111122 |
| 172 | galactose catabolic process (GO:0019388) | 2.42774392 |
| 173 | regulation of cell maturation (GO:1903429) | 2.41593367 |
| 174 | phenol-containing compound catabolic process (GO:0019336) | 2.41500803 |
| 175 | positive regulation of calcium ion transport into cytosol (GO:0010524) | 2.40608221 |
| 176 | viral transcription (GO:0019083) | 2.40162685 |
| 177 | cranial nerve development (GO:0021545) | 2.39963515 |
| 178 | dopamine receptor signaling pathway (GO:0007212) | 2.39243869 |
| 179 | leukocyte aggregation (GO:0070486) | 2.38961655 |
| 180 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.38445144 |
| 181 | DNA damage induced protein phosphorylation (GO:0006975) | 2.38355114 |
| 182 | protein targeting to mitochondrion (GO:0006626) | 2.38274431 |
| 183 | adenosine receptor signaling pathway (GO:0001973) | 2.38117417 |
| 184 | lipid storage (GO:0019915) | 2.37687843 |
| 185 | cAMP biosynthetic process (GO:0006171) | 2.37594334 |
| 186 | positive regulation of alcohol biosynthetic process (GO:1902932) | 2.36960897 |
| 187 | neuron projection regeneration (GO:0031102) | 2.36732565 |
| 188 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.35552137 |
| 189 | regulation of cholesterol metabolic process (GO:0090181) | 2.34805109 |
| 190 | chondroitin sulfate catabolic process (GO:0030207) | 2.33918363 |
| 191 | regulation of superoxide metabolic process (GO:0090322) | 2.33555537 |
| 192 | oligodendrocyte differentiation (GO:0048709) | 2.31635008 |
| 193 | negative regulation of organic acid transport (GO:0032891) | 2.30758128 |
| 194 | hydrogen peroxide catabolic process (GO:0042744) | 2.30592819 |
| 195 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.30177175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.38763247 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.92516313 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.74952600 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.71584677 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.68320821 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.63596081 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.55851208 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.52297390 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.13110343 |
| 10 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 3.00952095 |
| 11 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.97903561 |
| 12 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.97903561 |
| 13 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.97903561 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.78367987 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60283175 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43846904 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.41815152 |
| 18 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.41392785 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39207843 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.37233571 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.21807766 |
| 22 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.19895833 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.17414317 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.16467209 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.15658891 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.13271036 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.07377104 |
| 28 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.06840528 |
| 29 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.99760918 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.99323811 |
| 31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.97999803 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97402362 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.94238855 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89308815 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.87674217 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82685974 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.82152117 |
| 38 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.80455720 |
| 39 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.78970700 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.77363190 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74463108 |
| 42 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.73028498 |
| 43 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70852627 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.67458698 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64791472 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59830479 |
| 47 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57355475 |
| 48 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55711459 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51584864 |
| 50 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.49470013 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46689532 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46670863 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42028924 |
| 54 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.41916155 |
| 55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40496789 |
| 56 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.39788849 |
| 57 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.38565852 |
| 58 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38532707 |
| 59 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.36861855 |
| 60 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.36389672 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36333370 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35889620 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35544163 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34369430 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.34179497 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33857078 |
| 67 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.33793090 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.33683759 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33385753 |
| 70 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33049201 |
| 71 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32740393 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.32473655 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.32361913 |
| 74 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31393850 |
| 75 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.31387910 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31320189 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30356720 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29926913 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 1.29262992 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28482690 |
| 81 | MAF_26560356_Chip-Seq_TH1_Human | 1.26257704 |
| 82 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.25869067 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24202243 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24156384 |
| 85 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23931635 |
| 86 | SA1_27219007_Chip-Seq_Bcells_Human | 1.23321857 |
| 87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.23266752 |
| 88 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22678960 |
| 89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22395565 |
| 90 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.21356560 |
| 91 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.21260903 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17604392 |
| 93 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.15856667 |
| 94 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15224448 |
| 95 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14975415 |
| 96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14686942 |
| 97 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.14600468 |
| 98 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.14098069 |
| 99 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13892201 |
| 100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13864466 |
| 101 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.13571563 |
| 102 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12508394 |
| 103 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12015921 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12015921 |
| 105 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11399013 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10963778 |
| 107 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.10454285 |
| 108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10441582 |
| 109 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09551419 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05579744 |
| 111 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05315316 |
| 112 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05199392 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04244211 |
| 114 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.02993360 |
| 115 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02901599 |
| 116 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.02459920 |
| 117 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.02459920 |
| 118 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02419028 |
| 119 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01801910 |
| 120 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01725180 |
| 121 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00171961 |
| 122 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.00153040 |
| 123 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.99709513 |
| 124 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.99179835 |
| 125 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99042602 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98811780 |
| 127 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98742333 |
| 128 | MYB_26560356_Chip-Seq_TH1_Human | 0.98226989 |
| 129 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98214951 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97869992 |
| 131 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97020369 |
| 132 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.96980812 |
| 133 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96768685 |
| 134 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96747723 |
| 135 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.96570286 |
| 136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95828708 |
| 137 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95709028 |
| 138 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95394907 |
| 139 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95163323 |
| 140 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94821722 |
| 141 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94475663 |
| 142 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94307547 |
| 143 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93493387 |
| 144 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.93196140 |
| 145 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93122869 |
| 146 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.92983303 |
| 147 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.92246193 |
| 148 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.91982740 |
| 149 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90597079 |
| 150 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90246551 |
| 151 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90101289 |
| 152 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.89791341 |
| 153 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89465698 |
| 154 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89410613 |
| 155 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.89296378 |
| 156 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89267515 |
| 157 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.88922527 |
| 158 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88884961 |
| 159 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88321352 |
| 160 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87696499 |
| 161 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87403333 |
| 162 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87123176 |
| 163 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86840813 |
| 164 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86840813 |
| 165 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86501604 |
| 166 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86349696 |
| 167 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86210632 |
| 168 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.85711046 |
| 169 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85082541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 8.07872387 |
| 2 | MP0005670_abnormal_white_adipose | 6.42539990 |
| 3 | MP0001968_abnormal_touch/_nociception | 6.38002704 |
| 4 | MP0002736_abnormal_nociception_after | 5.93514516 |
| 5 | MP0001986_abnormal_taste_sensitivity | 5.69401434 |
| 6 | MP0002733_abnormal_thermal_nociception | 4.13867409 |
| 7 | MP0006276_abnormal_autonomic_nervous | 3.84998913 |
| 8 | MP0004270_analgesia | 3.83897875 |
| 9 | MP0001970_abnormal_pain_threshold | 3.75450343 |
| 10 | MP0005666_abnormal_adipose_tissue | 3.67953057 |
| 11 | MP0004185_abnormal_adipocyte_glucose | 3.65529491 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 3.39751959 |
| 13 | MP0003690_abnormal_glial_cell | 3.15494796 |
| 14 | MP0009379_abnormal_foot_pigmentation | 3.13899269 |
| 15 | MP0002971_abnormal_brown_adipose | 2.80301346 |
| 16 | MP0004858_abnormal_nervous_system | 2.73134538 |
| 17 | MP0005375_adipose_tissue_phenotype | 2.70626822 |
| 18 | MP0004130_abnormal_muscle_cell | 2.69136974 |
| 19 | MP0005671_abnormal_response_to | 2.53814249 |
| 20 | MP0009840_abnormal_foam_cell | 2.48407198 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.45912450 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 2.36313857 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 2.30061805 |
| 24 | MP0002751_abnormal_autonomic_nervous | 2.18852087 |
| 25 | MP0000343_altered_response_to | 2.14464210 |
| 26 | MP0003011_delayed_dark_adaptation | 2.07440644 |
| 27 | MP0003693_abnormal_embryo_hatching | 1.96359484 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.92227341 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.90364629 |
| 30 | MP0009115_abnormal_fat_cell | 1.88925731 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.85845892 |
| 32 | MP0003075_altered_response_to | 1.83740113 |
| 33 | MP0002970_abnormal_white_adipose | 1.79067767 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.78917720 |
| 35 | MP0003045_fibrosis | 1.77889960 |
| 36 | MP0000003_abnormal_adipose_tissue | 1.74925251 |
| 37 | MP0003879_abnormal_hair_cell | 1.73932235 |
| 38 | MP0001188_hyperpigmentation | 1.60646292 |
| 39 | MP0004885_abnormal_endolymph | 1.57890624 |
| 40 | MP0005535_abnormal_body_temperature | 1.57671666 |
| 41 | MP0005334_abnormal_fat_pad | 1.57623763 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.54816771 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54382558 |
| 44 | MP0003329_amyloid_beta_deposits | 1.52654080 |
| 45 | MP0003634_abnormal_glial_cell | 1.51902785 |
| 46 | MP0001270_distended_abdomen | 1.48679328 |
| 47 | MP0002272_abnormal_nervous_system | 1.48391216 |
| 48 | MP0002184_abnormal_innervation | 1.48270179 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.38380563 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.35716063 |
| 51 | MP0010329_abnormal_lipoprotein_level | 1.35335764 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.33826044 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.32274297 |
| 54 | MP0003279_aneurysm | 1.30726484 |
| 55 | MP0002067_abnormal_sensory_capabilities | 1.30084978 |
| 56 | MP0003724_increased_susceptibility_to | 1.29763492 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.28394161 |
| 58 | MP0001727_abnormal_embryo_implantation | 1.22573809 |
| 59 | MP0005452_abnormal_adipose_tissue | 1.22482185 |
| 60 | MP0009785_altered_susceptibility_to | 1.16722064 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.15246362 |
| 62 | MP0003959_abnormal_lean_body | 1.13463580 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.13279865 |
| 64 | MP0004859_abnormal_synaptic_plasticity | 1.11908380 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.09069006 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.08743771 |
| 67 | MP0002822_catalepsy | 1.08177802 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.07645395 |
| 69 | MP0001881_abnormal_mammary_gland | 1.06999958 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.05715916 |
| 71 | MP0005448_abnormal_energy_balance | 1.05253605 |
| 72 | MP0000920_abnormal_myelination | 1.04022184 |
| 73 | MP0000747_muscle_weakness | 1.03121156 |
| 74 | MP0002163_abnormal_gland_morphology | 1.01721398 |
| 75 | MP0005508_abnormal_skeleton_morphology | 1.01179094 |
| 76 | MP0008775_abnormal_heart_ventricle | 1.00649782 |
| 77 | MP0001800_abnormal_humoral_immune | 1.00280048 |
| 78 | MP0001853_heart_inflammation | 0.97531530 |
| 79 | MP0009384_cardiac_valve_regurgitation | 0.96189358 |
| 80 | MP0010030_abnormal_orbit_morphology | 0.95290453 |
| 81 | MP0005451_abnormal_body_composition | 0.94628154 |
| 82 | MP0001542_abnormal_bone_strength | 0.94317569 |
| 83 | MP0008874_decreased_physiological_sensi | 0.93843751 |
| 84 | MP0008260_abnormal_autophagy | 0.93550653 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 0.93512284 |
| 86 | MP0000762_abnormal_tongue_morphology | 0.93238235 |
| 87 | MP0003315_abnormal_perineum_morphology | 0.92879210 |
| 88 | MP0005332_abnormal_amino_acid | 0.92869208 |
| 89 | MP0001905_abnormal_dopamine_level | 0.92794552 |
| 90 | MP0000604_amyloidosis | 0.90906629 |
| 91 | MP0003136_yellow_coat_color | 0.90769123 |
| 92 | MP0000750_abnormal_muscle_regeneration | 0.90197829 |
| 93 | MP0005595_abnormal_vascular_smooth | 0.89551730 |
| 94 | MP0002006_tumorigenesis | 0.89044720 |
| 95 | MP0003942_abnormal_urinary_system | 0.86739139 |
| 96 | MP0003123_paternal_imprinting | 0.85993964 |
| 97 | MP0002653_abnormal_ependyma_morphology | 0.85847397 |
| 98 | MP0005083_abnormal_biliary_tract | 0.85427441 |
| 99 | MP0003633_abnormal_nervous_system | 0.84628496 |
| 100 | MP0000026_abnormal_inner_ear | 0.84503051 |
| 101 | MP0001944_abnormal_pancreas_morphology | 0.84073710 |
| 102 | MP0005423_abnormal_somatic_nervous | 0.83632343 |
| 103 | MP0004134_abnormal_chest_morphology | 0.82664908 |
| 104 | MP0001661_extended_life_span | 0.82572886 |
| 105 | MP0000613_abnormal_salivary_gland | 0.82088552 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.81104796 |
| 107 | MP0002234_abnormal_pharynx_morphology | 0.80133149 |
| 108 | MP0002723_abnormal_immune_serum | 0.78932228 |
| 109 | MP0002420_abnormal_adaptive_immunity | 0.77114181 |
| 110 | MP0004811_abnormal_neuron_physiology | 0.76994830 |
| 111 | MP0002148_abnormal_hypersensitivity_rea | 0.76840272 |
| 112 | MP0001529_abnormal_vocalization | 0.76522386 |
| 113 | MP0001440_abnormal_grooming_behavior | 0.75744576 |
| 114 | MP0003953_abnormal_hormone_level | 0.75454419 |
| 115 | MP0010386_abnormal_urinary_bladder | 0.74998672 |
| 116 | MP0002405_respiratory_system_inflammati | 0.74504857 |
| 117 | MP0001819_abnormal_immune_cell | 0.74299897 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.74079548 |
| 119 | MP0002398_abnormal_bone_marrow | 0.73905226 |
| 120 | MP0003137_abnormal_impulse_conducting | 0.73853697 |
| 121 | MP0000858_altered_metastatic_potential | 0.73745810 |
| 122 | MP0009780_abnormal_chondrocyte_physiolo | 0.73721819 |
| 123 | MP0008932_abnormal_embryonic_tissue | 0.72949647 |
| 124 | MP0003436_decreased_susceptibility_to | 0.72604154 |
| 125 | MP0008789_abnormal_olfactory_epithelium | 0.72486641 |
| 126 | MP0002160_abnormal_reproductive_system | 0.71894200 |
| 127 | MP0001756_abnormal_urination | 0.71825889 |
| 128 | MP0001764_abnormal_homeostasis | 0.69635099 |
| 129 | MP0000534_abnormal_ureter_morphology | 0.69234825 |
| 130 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68877326 |
| 131 | MP0006292_abnormal_olfactory_placode | 0.68557191 |
| 132 | MP0002166_altered_tumor_susceptibility | 0.68189821 |
| 133 | MP0000955_abnormal_spinal_cord | 0.67280253 |
| 134 | MP0008872_abnormal_physiological_respon | 0.66071623 |
| 135 | MP0005623_abnormal_meninges_morphology | 0.65659716 |
| 136 | MP0005025_abnormal_response_to | 0.65487639 |
| 137 | MP0000749_muscle_degeneration | 0.65353272 |
| 138 | MP0003705_abnormal_hypodermis_morpholog | 0.65199737 |
| 139 | MP0005647_abnormal_sex_gland | 0.65113538 |
| 140 | MP0009764_decreased_sensitivity_to | 0.63950730 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.63793984 |
| 142 | MP0001984_abnormal_olfaction | 0.63007179 |
| 143 | MP0001963_abnormal_hearing_physiology | 0.62564596 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.62349184 |
| 145 | MP0000678_abnormal_parathyroid_gland | 0.61823443 |
| 146 | MP0005165_increased_susceptibility_to | 0.61651994 |
| 147 | MP0005365_abnormal_bile_salt | 0.61236892 |
| 148 | MP0009250_abnormal_appendicular_skeleto | 0.61070735 |
| 149 | MP0000681_abnormal_thyroid_gland | 0.60814212 |
| 150 | MP0009643_abnormal_urine_homeostasis | 0.60539077 |
| 151 | MP0009745_abnormal_behavioral_response | 0.59167161 |
| 152 | MP0003656_abnormal_erythrocyte_physiolo | 0.59092813 |
| 153 | MP0000716_abnormal_immune_system | 0.59060799 |
| 154 | MP0001790_abnormal_immune_system | 0.58925073 |
| 155 | MP0005387_immune_system_phenotype | 0.58925073 |
| 156 | MP0005319_abnormal_enzyme/_coenzyme | 0.57725750 |
| 157 | MP0003635_abnormal_synaptic_transmissio | 0.57465612 |
| 158 | MP0000462_abnormal_digestive_system | 0.56706422 |
| 159 | MP0003638_abnormal_response/metabolism_ | 0.56589176 |
| 160 | MP0000013_abnormal_adipose_tissue | 0.56469923 |
| 161 | MP0001299_abnormal_eye_distance/ | 0.56295919 |
| 162 | MP0000427_abnormal_hair_cycle | 0.54066053 |
| 163 | MP0002882_abnormal_neuron_morphology | 0.53894420 |
| 164 | MP0000685_abnormal_immune_system | 0.53700061 |
| 165 | MP0003806_abnormal_nucleotide_metabolis | 0.53672575 |
| 166 | MP0006082_CNS_inflammation | 0.53595940 |
| 167 | MP0010771_integument_phenotype | 0.51089266 |
| 168 | MP0009046_muscle_twitch | 0.50915630 |
| 169 | MP0003186_abnormal_redox_activity | 0.50253381 |
| 170 | MP0002095_abnormal_skin_pigmentation | 0.49762830 |
| 171 | MP0002722_abnormal_immune_system | 0.48482514 |
| 172 | MP0002452_abnormal_antigen_presenting | 0.48434327 |
| 173 | MP0002572_abnormal_emotion/affect_behav | 0.48035261 |
| 174 | MP0005166_decreased_susceptibility_to | 0.47456356 |
| 175 | MP0000703_abnormal_thymus_morphology | 0.47121195 |
| 176 | MP0000579_abnormal_nail_morphology | 0.47043282 |
| 177 | MP0002064_seizures | 0.46024915 |
| 178 | MP0002752_abnormal_somatic_nervous | 0.45520760 |
| 179 | MP0002429_abnormal_blood_cell | 0.44543650 |
| 180 | MP0001845_abnormal_inflammatory_respons | 0.43443826 |
| 181 | MP0001919_abnormal_reproductive_system | 0.42949589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.50479833 |
| 2 | Ulnar claw (HP:0001178) | 5.81245409 |
| 3 | Dysautonomia (HP:0002459) | 5.57277312 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.98501321 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.98501321 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.98501321 |
| 7 | Myotonia (HP:0002486) | 4.91416713 |
| 8 | Neuroendocrine neoplasm (HP:0100634) | 4.89642084 |
| 9 | Pheochromocytoma (HP:0002666) | 4.38381483 |
| 10 | Impaired pain sensation (HP:0007328) | 4.28251869 |
| 11 | Abnormality of pain sensation (HP:0010832) | 4.28251869 |
| 12 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.73736995 |
| 13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.60706169 |
| 14 | Increased muscle lipid content (HP:0009058) | 3.56777127 |
| 15 | Irregular epiphyses (HP:0010582) | 3.55284105 |
| 16 | Vertebral compression fractures (HP:0002953) | 3.50367874 |
| 17 | Action tremor (HP:0002345) | 3.48542764 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.41695616 |
| 19 | Thoracolumbar scoliosis (HP:0002944) | 3.37666650 |
| 20 | Neoplasm of the peripheral nervous system (HP:0100007) | 3.31532470 |
| 21 | Hypothermia (HP:0002045) | 3.29568129 |
| 22 | Abnormality of magnesium homeostasis (HP:0004921) | 3.29287562 |
| 23 | Renal Fanconi syndrome (HP:0001994) | 3.28689851 |
| 24 | Distal arthrogryposis (HP:0005684) | 3.22124615 |
| 25 | Hypercortisolism (HP:0001578) | 3.15396745 |
| 26 | Hepatic necrosis (HP:0002605) | 3.13429016 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 3.11157316 |
| 28 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.08057258 |
| 29 | Acute encephalopathy (HP:0006846) | 3.07717239 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.05410211 |
| 31 | Foot dorsiflexor weakness (HP:0009027) | 3.03321450 |
| 32 | Oligomenorrhea (HP:0000876) | 3.02622313 |
| 33 | Hypokinesia (HP:0002375) | 3.01755542 |
| 34 | Abnormal hair whorl (HP:0010721) | 2.96587339 |
| 35 | Truncus arteriosus (HP:0001660) | 2.95794538 |
| 36 | Sensory axonal neuropathy (HP:0003390) | 2.93812571 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.88552714 |
| 38 | Anomalous pulmonary venous return (HP:0010772) | 2.84850213 |
| 39 | Axonal loss (HP:0003447) | 2.80763566 |
| 40 | Insidious onset (HP:0003587) | 2.77841141 |
| 41 | Termporal pattern (HP:0011008) | 2.77841141 |
| 42 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.76750561 |
| 43 | Increased CSF lactate (HP:0002490) | 2.76489369 |
| 44 | Abnormal ciliary motility (HP:0012262) | 2.73893575 |
| 45 | Hyperthyroidism (HP:0000836) | 2.72986375 |
| 46 | Hypomagnesemia (HP:0002917) | 2.71791202 |
| 47 | Areflexia of lower limbs (HP:0002522) | 2.70920486 |
| 48 | Acanthosis nigricans (HP:0000956) | 2.64596195 |
| 49 | Nuclear cataract (HP:0100018) | 2.61818569 |
| 50 | Polyphagia (HP:0002591) | 2.61451439 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.59252392 |
| 52 | Curly hair (HP:0002212) | 2.57155785 |
| 53 | Abnormality of the foot musculature (HP:0001436) | 2.56373609 |
| 54 | Neurofibrillary tangles (HP:0002185) | 2.54769184 |
| 55 | Redundant skin (HP:0001582) | 2.51639418 |
| 56 | Carpal bone hypoplasia (HP:0001498) | 2.47879635 |
| 57 | Recurrent bronchitis (HP:0002837) | 2.47194674 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.46424295 |
| 59 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.46424295 |
| 60 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.46043591 |
| 61 | Hypertriglyceridemia (HP:0002155) | 2.44735858 |
| 62 | Failure to thrive in infancy (HP:0001531) | 2.44193284 |
| 63 | Respiratory failure (HP:0002878) | 2.42655763 |
| 64 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.41469765 |
| 65 | Abnormality of the vocal cords (HP:0008777) | 2.40769118 |
| 66 | Thyroid carcinoma (HP:0002890) | 2.40767648 |
| 67 | Peripheral hypomyelination (HP:0007182) | 2.40715302 |
| 68 | Decreased muscle mass (HP:0003199) | 2.40533718 |
| 69 | Barrel-shaped chest (HP:0001552) | 2.37776197 |
| 70 | Autoamputation (HP:0001218) | 2.37634419 |
| 71 | Steppage gait (HP:0003376) | 2.37450650 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 2.36930907 |
| 73 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.36079418 |
| 74 | Submucous cleft hard palate (HP:0000176) | 2.35729209 |
| 75 | Ragged-red muscle fibers (HP:0003200) | 2.34659364 |
| 76 | Spastic paraparesis (HP:0002313) | 2.34041308 |
| 77 | Abnormality of the pulmonary veins (HP:0011718) | 2.33041021 |
| 78 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.32350415 |
| 79 | Neoplasm of head and neck (HP:0012288) | 2.31928998 |
| 80 | Esophageal neoplasm (HP:0100751) | 2.31928998 |
| 81 | Down-sloping shoulders (HP:0200021) | 2.31417757 |
| 82 | Opisthotonus (HP:0002179) | 2.31018364 |
| 83 | Metaphyseal dysplasia (HP:0100255) | 2.30334047 |
| 84 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.29921989 |
| 85 | Increased hepatocellular lipid droplets (HP:0006565) | 2.28887374 |
| 86 | Exercise intolerance (HP:0003546) | 2.26373111 |
| 87 | Rhinitis (HP:0012384) | 2.25182844 |
| 88 | Nausea (HP:0002018) | 2.24585601 |
| 89 | Hypoplastic left heart (HP:0004383) | 2.22650874 |
| 90 | Double outlet right ventricle (HP:0001719) | 2.22643966 |
| 91 | Congenital malformation of the right heart (HP:0011723) | 2.22643966 |
| 92 | Lactic acidosis (HP:0003128) | 2.21999685 |
| 93 | CNS demyelination (HP:0007305) | 2.21391548 |
| 94 | Patent foramen ovale (HP:0001655) | 2.21158745 |
| 95 | Lipid accumulation in hepatocytes (HP:0006561) | 2.21039705 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.21012646 |
| 97 | Increased serum pyruvate (HP:0003542) | 2.19633065 |
| 98 | Myocardial infarction (HP:0001658) | 2.19335976 |
| 99 | Occipital encephalocele (HP:0002085) | 2.16749635 |
| 100 | Prolonged neonatal jaundice (HP:0006579) | 2.16609061 |
| 101 | Arthropathy (HP:0003040) | 2.14870940 |
| 102 | Sensorimotor neuropathy (HP:0007141) | 2.14309583 |
| 103 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.13939705 |
| 104 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.13939705 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 2.13057564 |
| 106 | Muscle stiffness (HP:0003552) | 2.12461465 |
| 107 | Retinal dysplasia (HP:0007973) | 2.10484197 |
| 108 | Impaired proprioception (HP:0010831) | 2.10292190 |
| 109 | Generalized aminoaciduria (HP:0002909) | 2.08662805 |
| 110 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08607712 |
| 111 | Overriding aorta (HP:0002623) | 2.07808895 |
| 112 | Hypercalcemia (HP:0003072) | 2.07782358 |
| 113 | Hyperparathyroidism (HP:0000843) | 2.07442790 |
| 114 | Severe combined immunodeficiency (HP:0004430) | 2.06777304 |
| 115 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.05794952 |
| 116 | Atonic seizures (HP:0010819) | 2.03804464 |
| 117 | Cerebral edema (HP:0002181) | 2.02308079 |
| 118 | Menstrual irregularities (HP:0000858) | 2.01754366 |
| 119 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01211978 |
| 120 | Abnormal hemoglobin (HP:0011902) | 2.01140197 |
| 121 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.00998527 |
| 122 | Hepatocellular necrosis (HP:0001404) | 1.98409951 |
| 123 | Neuroblastoma (HP:0003006) | 1.97093352 |
| 124 | Primitive neuroectodermal tumor (HP:0030065) | 1.97093352 |
| 125 | Neuroblastic tumors (HP:0004376) | 1.97093352 |
| 126 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.97093352 |
| 127 | Polar cataract (HP:0010696) | 1.96761869 |
| 128 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.96680032 |
| 129 | Paraparesis (HP:0002385) | 1.96436160 |
| 130 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.96264741 |
| 131 | Hydroureter (HP:0000072) | 1.96026191 |
| 132 | Mutism (HP:0002300) | 1.95270764 |
| 133 | Febrile seizures (HP:0002373) | 1.93984467 |
| 134 | Increased IgM level (HP:0003496) | 1.93368388 |
| 135 | Abnormal eating behavior (HP:0100738) | 1.93234888 |
| 136 | Cerebral hypomyelination (HP:0006808) | 1.92157480 |
| 137 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.91814748 |
| 138 | Short nail (HP:0001799) | 1.91797413 |
| 139 | Absent epiphyses (HP:0010577) | 1.91527671 |
| 140 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.91527671 |
| 141 | Acute necrotizing encephalopathy (HP:0006965) | 1.91016744 |
| 142 | Abnormal large intestine physiology (HP:0012700) | 1.89574994 |
| 143 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.89567580 |
| 144 | Hepatosplenomegaly (HP:0001433) | 1.88990010 |
| 145 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.88285281 |
| 146 | Abnormality of femoral epiphyses (HP:0006499) | 1.88285281 |
| 147 | Insulin resistance (HP:0000855) | 1.88221952 |
| 148 | Cerebral inclusion bodies (HP:0100314) | 1.88112746 |
| 149 | Abnormality of glycolysis (HP:0004366) | 1.88019371 |
| 150 | Insomnia (HP:0100785) | 1.87532223 |
| 151 | Growth hormone excess (HP:0000845) | 1.87427969 |
| 152 | Mitochondrial inheritance (HP:0001427) | 1.86266156 |
| 153 | Split foot (HP:0001839) | 1.84012096 |
| 154 | Emotional lability (HP:0000712) | 1.83423703 |
| 155 | Potter facies (HP:0002009) | 1.83374461 |
| 156 | Facial shape deformation (HP:0011334) | 1.83374461 |
| 157 | Abnormal sex determination (HP:0012244) | 1.81536049 |
| 158 | Sex reversal (HP:0012245) | 1.81536049 |
| 159 | Striae distensae (HP:0001065) | 1.80837301 |
| 160 | Episodic fever (HP:0001954) | 1.80687581 |
| 161 | Type I transferrin isoform profile (HP:0003642) | 1.80621105 |
| 162 | Complement deficiency (HP:0004431) | 1.80083318 |
| 163 | Short tibia (HP:0005736) | 1.80048572 |
| 164 | Xanthomatosis (HP:0000991) | 1.79544160 |
| 165 | Abnormality of the aortic arch (HP:0012303) | 1.79402385 |
| 166 | Dysostosis multiplex (HP:0000943) | 1.77702431 |
| 167 | Back pain (HP:0003418) | 1.77318502 |
| 168 | Delusions (HP:0000746) | 1.76136710 |
| 169 | Bradycardia (HP:0001662) | 1.76028767 |
| 170 | Popliteal pterygium (HP:0009756) | 1.75948224 |
| 171 | Lack of skin elasticity (HP:0100679) | 1.73619693 |
| 172 | Annular pancreas (HP:0001734) | 1.73337991 |
| 173 | Loss of speech (HP:0002371) | 1.73191072 |
| 174 | Hyperglycinemia (HP:0002154) | 1.73102778 |
| 175 | Focal seizures (HP:0007359) | 1.72829034 |
| 176 | Elfin facies (HP:0004428) | 1.71640443 |
| 177 | Abnormality of the femoral head (HP:0003368) | 1.71083750 |
| 178 | 3-Methylglutaconic aciduria (HP:0003535) | 1.70999481 |
| 179 | Concave nail (HP:0001598) | 1.70319761 |
| 180 | Hypoglycemic coma (HP:0001325) | 1.70138292 |
| 181 | Increased serum lactate (HP:0002151) | 1.69359985 |
| 182 | Rhabdomyolysis (HP:0003201) | 1.68341329 |
| 183 | Bowel incontinence (HP:0002607) | 1.67007234 |
| 184 | Hyperacusis (HP:0010780) | 1.66616493 |
| 185 | Exertional dyspnea (HP:0002875) | 1.66411106 |
| 186 | Chronic sinusitis (HP:0011109) | 1.65749901 |
| 187 | Mesangial abnormality (HP:0001966) | 1.64997773 |
| 188 | Testicular atrophy (HP:0000029) | 1.64730633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK5 | 5.93700553 |
| 2 | LIMK1 | 3.63107540 |
| 3 | NME2 | 3.37029074 |
| 4 | KSR2 | 3.30268525 |
| 5 | MAP3K2 | 3.22639773 |
| 6 | ABL2 | 3.17284092 |
| 7 | BCKDK | 3.15087577 |
| 8 | MAP3K12 | 3.00342678 |
| 9 | NTRK1 | 2.95834368 |
| 10 | IRAK3 | 2.83733438 |
| 11 | PBK | 2.68504499 |
| 12 | MST4 | 2.32142878 |
| 13 | MAP3K9 | 2.25381568 |
| 14 | RIPK4 | 2.11156864 |
| 15 | VRK2 | 2.00547222 |
| 16 | CAMK2G | 1.93753355 |
| 17 | LMTK2 | 1.79773641 |
| 18 | NTRK3 | 1.73603668 |
| 19 | EPHA2 | 1.69657533 |
| 20 | PRPF4B | 1.67483877 |
| 21 | MARK3 | 1.66576432 |
| 22 | TXK | 1.66151182 |
| 23 | MATK | 1.65657929 |
| 24 | ADRBK2 | 1.62641739 |
| 25 | PKN1 | 1.62168268 |
| 26 | SIK1 | 1.57222047 |
| 27 | TESK1 | 1.54338615 |
| 28 | TRIB3 | 1.50551043 |
| 29 | DDR2 | 1.48299319 |
| 30 | TESK2 | 1.48047647 |
| 31 | STK16 | 1.46246573 |
| 32 | MET | 1.43150556 |
| 33 | SIK3 | 1.42813116 |
| 34 | CSNK1G2 | 1.41868760 |
| 35 | MINK1 | 1.41274057 |
| 36 | CSNK1G3 | 1.40579696 |
| 37 | MAP3K1 | 1.39761152 |
| 38 | CAMK2D | 1.38842523 |
| 39 | NEK9 | 1.38106359 |
| 40 | ERN1 | 1.37962543 |
| 41 | CAMK2B | 1.36819277 |
| 42 | EPHB2 | 1.32507037 |
| 43 | TYK2 | 1.32481091 |
| 44 | ARAF | 1.31348912 |
| 45 | PRKD3 | 1.29477869 |
| 46 | MAPKAPK3 | 1.28356789 |
| 47 | CDK9 | 1.27559981 |
| 48 | RET | 1.25352961 |
| 49 | TNK2 | 1.24376219 |
| 50 | MAP3K11 | 1.23468615 |
| 51 | LATS2 | 1.23338544 |
| 52 | MST1R | 1.22548019 |
| 53 | CASK | 1.21482933 |
| 54 | MAP4K1 | 1.21286698 |
| 55 | JAK3 | 1.19265100 |
| 56 | ZAP70 | 1.15822495 |
| 57 | PAK4 | 1.15788720 |
| 58 | TAOK2 | 1.13639728 |
| 59 | IKBKE | 1.12480944 |
| 60 | KDR | 1.10773438 |
| 61 | CSNK1A1L | 1.09342165 |
| 62 | CSNK1G1 | 1.07925341 |
| 63 | NTRK2 | 1.06023004 |
| 64 | SMG1 | 1.04811651 |
| 65 | PTK2 | 1.02377308 |
| 66 | LCK | 1.00459711 |
| 67 | ITK | 0.99814866 |
| 68 | EPHA3 | 0.99039919 |
| 69 | MAPK13 | 0.97426952 |
| 70 | BRAF | 0.96761241 |
| 71 | FGFR4 | 0.95141665 |
| 72 | SGK2 | 0.93426171 |
| 73 | ERBB4 | 0.92940194 |
| 74 | MYLK | 0.92290012 |
| 75 | MAP2K1 | 0.91421924 |
| 76 | JAK1 | 0.90785463 |
| 77 | BUB1 | 0.88831692 |
| 78 | FGFR3 | 0.86977309 |
| 79 | SGK494 | 0.83425952 |
| 80 | SGK223 | 0.83425952 |
| 81 | MAP2K2 | 0.79645611 |
| 82 | TBK1 | 0.79419502 |
| 83 | TEC | 0.78667350 |
| 84 | BMX | 0.78069697 |
| 85 | NLK | 0.74951820 |
| 86 | AURKA | 0.73142827 |
| 87 | LRRK2 | 0.72632511 |
| 88 | PIM2 | 0.72344258 |
| 89 | RIPK1 | 0.72318870 |
| 90 | MOS | 0.71847234 |
| 91 | TYRO3 | 0.71258072 |
| 92 | RPS6KB2 | 0.70397248 |
| 93 | DAPK2 | 0.69502847 |
| 94 | FLT3 | 0.69325879 |
| 95 | FES | 0.68474582 |
| 96 | AKT2 | 0.68282520 |
| 97 | MAP2K6 | 0.67219126 |
| 98 | MAP2K3 | 0.66817437 |
| 99 | CDK14 | 0.65570832 |
| 100 | PDGFRA | 0.62751950 |
| 101 | MAP3K3 | 0.61604575 |
| 102 | PRKCH | 0.60619771 |
| 103 | ADRBK1 | 0.58798448 |
| 104 | DYRK3 | 0.58118552 |
| 105 | STK24 | 0.57246946 |
| 106 | TSSK6 | 0.56716746 |
| 107 | PRKCI | 0.56288715 |
| 108 | YES1 | 0.54458500 |
| 109 | PLK2 | 0.53227922 |
| 110 | SCYL2 | 0.53049893 |
| 111 | FER | 0.51353334 |
| 112 | SYK | 0.49616613 |
| 113 | ROCK2 | 0.47487916 |
| 114 | ILK | 0.47392738 |
| 115 | TAOK1 | 0.46701481 |
| 116 | EIF2AK1 | 0.46502339 |
| 117 | PTK2B | 0.46458812 |
| 118 | RPS6KA5 | 0.46433536 |
| 119 | CDK8 | 0.45778566 |
| 120 | MAPK12 | 0.45491975 |
| 121 | RPS6KA2 | 0.45046634 |
| 122 | EIF2AK3 | 0.44772726 |
| 123 | PRKG2 | 0.44660437 |
| 124 | PHKG1 | 0.43905460 |
| 125 | PHKG2 | 0.43905460 |
| 126 | CAMK2A | 0.42555293 |
| 127 | PINK1 | 0.41829324 |
| 128 | CSF1R | 0.41365332 |
| 129 | PAK1 | 0.40482961 |
| 130 | DYRK2 | 0.40399445 |
| 131 | NEK6 | 0.40126095 |
| 132 | CSNK1A1 | 0.40073361 |
| 133 | PRKCD | 0.39971243 |
| 134 | PDPK1 | 0.39020326 |
| 135 | MAPKAPK5 | 0.37519018 |
| 136 | BTK | 0.35175915 |
| 137 | SGK3 | 0.34858730 |
| 138 | STK38L | 0.34279753 |
| 139 | STK10 | 0.34251636 |
| 140 | BMPR1B | 0.34152701 |
| 141 | MAPK11 | 0.34041804 |
| 142 | PDK2 | 0.33879737 |
| 143 | PRKACA | 0.33433959 |
| 144 | GSK3A | 0.33217525 |
| 145 | IRAK2 | 0.32965306 |
| 146 | DAPK1 | 0.31698048 |
| 147 | CSNK2A1 | 0.31639472 |
| 148 | ROCK1 | 0.31466621 |
| 149 | STK38 | 0.31128250 |
| 150 | MAP2K7 | 0.30776758 |
| 151 | DAPK3 | 0.30717636 |
| 152 | HIPK2 | 0.29528940 |
| 153 | MAPK4 | 0.28969474 |
| 154 | CAMK1D | 0.28859326 |
| 155 | CDK5 | 0.28734352 |
| 156 | SRC | 0.28700143 |
| 157 | MAPKAPK2 | 0.28542105 |
| 158 | PRKD1 | 0.26939591 |
| 159 | EPHB1 | 0.26732918 |
| 160 | STK4 | 0.26052116 |
| 161 | CAMK1 | 0.25930191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.90536810 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.81798465 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 3.67529131 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.06420726 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.93530156 |
| 6 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.91436590 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.73206014 |
| 8 | Thyroid cancer_Homo sapiens_hsa05216 | 2.68293304 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.54784296 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.53348240 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.46770145 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.29910627 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.21942388 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.18965530 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.15453873 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 2.13209983 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01560763 |
| 18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.97851019 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.94920706 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94728989 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.89495527 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88554223 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88052190 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.88010480 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.85830968 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84002294 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.84001299 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79072479 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.77455147 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73463063 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.72822478 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70195218 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69934586 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64342595 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63500316 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60295236 |
| 37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.58273040 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56728617 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56422775 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54667521 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52962308 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.50712863 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.50183000 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49570845 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45390395 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40717178 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.39698027 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.39386375 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39134839 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38804804 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35796076 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31794987 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30623916 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26063332 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23827553 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.22501287 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 1.21435251 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.20898294 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19784694 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.18544653 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14851847 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.09022664 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07610555 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05585759 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04054862 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98116875 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95103752 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94008818 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93259638 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93145175 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92359811 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90839944 |
| 73 | Insulin secretion_Homo sapiens_hsa04911 | 0.90752186 |
| 74 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90481670 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.90254052 |
| 76 | Melanoma_Homo sapiens_hsa05218 | 0.88996970 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.88964163 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88892882 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.87432814 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87063509 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85831102 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.83024056 |
| 83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81065896 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.80190409 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80103629 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79395107 |
| 87 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78209403 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.78191767 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77027617 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76697188 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75292112 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.74668936 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73653603 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72008221 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71953766 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71624522 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71507577 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71367905 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71099321 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68528904 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68250831 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.67672710 |
| 103 | Protein export_Homo sapiens_hsa03060 | 0.65602936 |
| 104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63721690 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62681888 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62114593 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.62053073 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.60339219 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60207156 |
| 110 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58041646 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57820436 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56377571 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55629799 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.54921304 |
| 115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53903479 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53235486 |
| 117 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52079235 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51452626 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51390624 |
| 120 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51062125 |
| 121 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50809364 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50571570 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50147753 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49796897 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49530962 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.48962950 |
| 127 | Purine metabolism_Homo sapiens_hsa00230 | 0.48222581 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48102201 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.47961911 |
| 130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47509758 |
| 131 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47231295 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47128492 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.46469361 |
| 134 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45729414 |
| 135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44830561 |
| 136 | Salivary secretion_Homo sapiens_hsa04970 | 0.44495800 |
| 137 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43954433 |
| 138 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43923279 |
| 139 | Gap junction_Homo sapiens_hsa04540 | 0.43488052 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43120487 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.42322959 |
| 142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41993278 |
| 143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40097515 |
| 144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39909957 |
| 145 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39617593 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.39418996 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38905643 |
| 148 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38424894 |
| 149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37478067 |
| 150 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37018295 |
| 151 | DNA replication_Homo sapiens_hsa03030 | 0.35509160 |
| 152 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35201799 |
| 153 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34569716 |
| 154 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33669708 |
| 155 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32472479 |
| 156 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31969694 |
| 157 | Long-term depression_Homo sapiens_hsa04730 | 0.31780892 |
| 158 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.31195133 |
| 159 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30983221 |
| 160 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30740330 |
| 161 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30375925 |
| 162 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29724780 |
| 163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27328445 |
| 164 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23151313 |
| 165 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21520754 |
| 166 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19351859 |
| 167 | Malaria_Homo sapiens_hsa05144 | 0.16164662 |
| 168 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.15402009 |
| 169 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14500858 |
| 170 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.13813719 |
| 171 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.12075803 |

